학술논문
Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial
Document Type
Article
Author
Source
In Respiratory Medicine October 2021 187
Subject
Language
ISSN
0954-6111